Prosecution Insights
Last updated: November 04, 2026

Nikolai Merkin

Technology area: Biotechnology & Pharmaceuticals

2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready

Analysis

Nikolai Merkin is currently managing 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 2 distinct examiners, which indicates that each application is being reviewed by a different individual. This lack of examiner overlap requires the applicant to manage multiple distinct prosecution tracks simultaneously. Furthermore, the cases are located in 2 distinct art units, suggesting that the portfolio covers diverse technical subjects within the broader biotechnology field.

The busiest examiner for the portfolio is LARA, CAROLINE MONSERRAT, who is responsible for 1 busiest examiner pending action. Since the total number of 2 pending office actions is split, this examiner handles a portion of the current workload at the USPTO. The other pending action is managed by a different 2 distinct examiner in a separate art unit. This structure indicates a decentralized prosecution landscape where 2 distinct examiners and 2 distinct art units are involved, necessitating a flexible approach to patent acquisition. The presence of 1 busiest examiner pending action with LARA, CAROLINE MONSERRAT means the workload is divided.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

2
Total Pending OAs
1
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
0
Due this month
1
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (50%)
Multi-statute (no §101)1 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

20 h
Manual time on pending OAs
4 h
Time saved (low, 20%)
7 h
Time saved (mid, 35%)
0.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
LARA, CAROLINE MONSERRAT 1 87.5% +16.7%
SKIBINSKY, ANNA 1 39.1% +29.3%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18534476 METHOD, DEVICE, AND CARDIOPLEGIC SOLUTION FOR THE PRESERVATION OF A DONOR HEART LARA, CAROLINE MONSERRAT 43d
18470740 METHOD AND DEVICE FOR DETERMINING ISCHEMIC INJURIES OF MAMMALIAN ORGANS AND TISSUES SKIBINSKY, ANNA —

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18534476 METHOD, DEVICE, AND CARDIOPLEGIC SOLUTION FOR THE PRESERVATION OF A DONOR HEART LARA, CAROLINE MONSERRAT 43d
18470740 METHOD AND DEVICE FOR DETERMINING ISCHEMIC INJURIES OF MAMMALIAN ORGANS AND TISSUES SKIBINSKY, ANNA —

Top Art Units

Art UnitApps
1633 1
1635 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18534476 METHOD, DEVICE, AND CARDIOPLEGIC SOLUTION FOR THE PRESERVATION OF A DONOR HEART LARA, CAROLINE MONSERRAT 1633 §102§103 Final Rejection 43d Pending Dec 08, 2023
18470740 METHOD AND DEVICE FOR DETERMINING ISCHEMIC INJURIES OF MAMMALIAN ORGANS AND TISSUES SKIBINSKY, ANNA 1635 §101§102§103§112 Non-Final OA — Pending Sep 20, 2023

Managing Nikolai Merkin's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Nikolai Merkin have?

Nikolai Merkin has 2 pending office actions as of November 2026, spread across 2 art units and 2 examiners.

Which USPTO examiner handles the most Nikolai Merkin applications?

Caroline Monserrat Lara has the most, with 1 of Nikolai Merkin's pending office actions.

What technology area are Nikolai Merkin's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month